Variable-region-identical mouse immunoglobulin G1 (IgG1), IgG2b, and IgG2a monoclonal
antibodies to the capsular polysaccharide of Cryptococcus neoformans prolong the lives of …

Vaccination and infection can elicit protective and nonprotective antibodies to the fungus
Cryptococcus neoformans in mice. The effect of nonprotective antibodies on host defense is …

Passive administration of monoclonal antibodies (MAbs) to the capsular polysaccharide of
Cryptococcus neoformans can alter the course of infection in mice. In a murine model of …

Monoclonal antibodies (MAbs) to the capsular polysaccharide of the pathogenic fungus
Cryptococcus neoformans can prolong survival and decrease organ fungal burden in …

Cryptococcus neoformans, the etiological agent of cryptococcosis, is an occasional
opportunistic fungal pathogen of immune competent individuals. However, it is a relatively …

Cryptococcus neoformans is an encapsulated fungus that is a major cause of meningitis in
patients with AIDS. In immunocompetent mice, administration of IgG1 mAb protects against …

Cryptococcus neoformans, an opportunistic fungal pathogen, often causes serious and life-
threatening infections in immunocompromised hosts as well as in normal individuals. In the …

Several murine monoclonal antibodies (MAbs) specific for the capsular
glucuronoxylomannan of Cryptococcus neoformans were studied for their capacity to confer …

Cryptococcus neoformans is an encapsulated fungus that is a frequent cause of
lifethreatening infections in patients with AIDS. C. neoformans has many similarities with …

The role of interleukin (IL)-4 in cryptococcal disease was studied in IL-4 knockout (IL-4KO)
and wild-type (WT) mice infected with Cryptococcus neoformans isolates that vary widely in …